Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature.
Cripps AW, Folaranmi T, Johnson KD, Musey L, Niederman MS, Buchwald UK. Cripps AW, et al. Among authors: johnson kd. Expert Rev Vaccines. 2021 Mar;20(3):257-267. doi: 10.1080/14760584.2021.1889374. Epub 2021 Mar 2. Expert Rev Vaccines. 2021. PMID: 33567914 Free article. Review.
Cost and health impact analysis of herpes zoster vaccination in Norway.
Flem E, Graham J, Yi Z, Wisløff T, Johnson KD. Flem E, et al. Among authors: johnson kd. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):315-326. doi: 10.1080/14737167.2021.1973893. Epub 2021 Sep 12. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34488508
Health economic evaluation of introducing a PPSV23-based vaccination programme to adults aged 65 and above, and an extension to the 60-64 age group in Denmark.
Birck AM, Nordin Christensen L, Pedersen MH, Olsen J, Johnson KD, Bencina G, Clausen TH, Larsen CS. Birck AM, et al. Among authors: johnson kd. Expert Rev Vaccines. 2021 Oct;20(10):1327-1337. doi: 10.1080/14760584.2021.1977627. Epub 2021 Sep 16. Expert Rev Vaccines. 2021. PMID: 34488534 Free article.
Response to Vyse et al., "A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK".
Dawson R, Buchwald UK, Johnson KD, Spowart L. Dawson R, et al. Among authors: johnson kd. Expert Rev Vaccines. 2022 Jun;21(6):869-870. doi: 10.1080/14760584.2022.2047023. Epub 2022 Mar 22. Expert Rev Vaccines. 2022. PMID: 35285368 Free article. No abstract available.
284 results